{"id":"https://openalex.org/W1982166376","doi":"https://doi.org/10.1097/00004583-199501000-00013","title":"An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder","display_name":"An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W1982166376","doi":"https://doi.org/10.1097/00004583-199501000-00013","mag":"1982166376","pmid":"https://pubmed.ncbi.nlm.nih.gov/7860456"},"language":"en","primary_location":{"id":"doi:10.1097/00004583-199501000-00013","doi":"https://doi.org/10.1097/00004583-199501000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004583-199501000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S60711021","display_name":"Journal of the American Academy of Child & Adolescent Psychiatry","issn_l":"0890-8567","issn":["0890-8567","1527-5418"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Child & Adolescent Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103427936","display_name":"Robert D. Hunt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096570","display_name":"Vanderbilt Psychiatric Hospital","ror":"https://ror.org/0118bqm57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096570","https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert D. Hunt","raw_affiliation_strings":["Division of Child Psychiatry, Vanderbilt University School of Medicine, Nashville, TN","Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt","Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine","Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Child Psychiatry, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210096570"]},{"raw_affiliation_string":"Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019453928","display_name":"Amy F.T. Arnsten","orcid":"https://orcid.org/0000-0002-3420-1308","observed_orcids":["https://orcid.org/0000-0002-3420-1308"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096570","display_name":"Vanderbilt Psychiatric Hospital","ror":"https://ror.org/0118bqm57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096570","https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy F.T. Arnsten","raw_affiliation_strings":["Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine; Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt; and Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt","Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine","Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine; Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt; and Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I32971472","https://openalex.org/I4210096570"]},{"raw_affiliation_string":"Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210096570"]},{"raw_affiliation_string":"Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023626552","display_name":"Matthew D. Asbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096570","display_name":"Vanderbilt Psychiatric Hospital","ror":"https://ror.org/0118bqm57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096570","https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew D. Asbell","raw_affiliation_strings":["Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine; Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt; and Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt","Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine","Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine; Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt; and Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I32971472","https://openalex.org/I4210096570"]},{"raw_affiliation_string":"Director of Psychopharmacology Training & Psychopharmacology Committee, Psychiatric Hospital at Vanderbilt","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210096570"]},{"raw_affiliation_string":"Dr. Hunt is Associate Clinical Professor of Psychiatry, Division of Child Psychiatry, Vanderbilt University School of Medicine","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Medical Director, Center for Attention & Hyperactivity Disorders, Nashville, TN. Dr. Arnsten is Assistant Professor of Neurobiology, Yale University School of Medicine, New Haven, CT. Matthew Asbell is Director of Research & Development, Center for Attention & Hyperactivity Disorders","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5103427936"],"corresponding_institution_ids":["https://openalex.org/I200719446","https://openalex.org/I32971472","https://openalex.org/I4210096570"],"apc_list":{"value":3710,"currency":"USD","value_usd":3710},"apc_paid":null,"fwci":12.2259,"has_fulltext":false,"cited_by_count":306,"citation_normalized_percentile":{"value":0.99153582,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"34","issue":"1","first_page":"50","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/guanfacine","display_name":"guanfacine","score":1.0},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9710000157356262},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-agonists","display_name":"alpha-2 adrenergic agonists","score":0.8859999775886536},{"id":"https://openalex.org/keywords/adhd-medication","display_name":"ADHD medication","score":0.7129999995231628},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.8859999775886536},{"id":"https://openalex.org/keywords/inattention","display_name":"inattention","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sedative-side-effects","display_name":"sedative side effects","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2780815205","wikidata":"https://www.wikidata.org/wiki/Q5613599","display_name":"Guanfacine","level":3,"score":0.9949691295623779},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.8350775241851807},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.7707998752593994},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6862554550170898},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5777859687805176},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.5323363542556763},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.439056932926178},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.43392103910446167},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35104554891586304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3293772041797638},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2254074513912201},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004583-199501000-00013","doi":"https://doi.org/10.1097/00004583-199501000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004583-199501000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S60711021","display_name":"Journal of the American Academy of Child & Adolescent Psychiatry","issn_l":"0890-8567","issn":["0890-8567","1527-5418"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Child & Adolescent Psychiatry","raw_type":"journal-article"},{"id":"pmid:7860456","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7860456","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Child and Adolescent Psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1232286304","https://openalex.org/W1603121691","https://openalex.org/W1873661387","https://openalex.org/W1970875415","https://openalex.org/W1973930439","https://openalex.org/W1999403328","https://openalex.org/W2000247756","https://openalex.org/W2002691701","https://openalex.org/W2016109861","https://openalex.org/W2029643412","https://openalex.org/W2060345740","https://openalex.org/W2062472920","https://openalex.org/W2064396657","https://openalex.org/W2067197183","https://openalex.org/W2067292897","https://openalex.org/W2070083719","https://openalex.org/W2073571349","https://openalex.org/W2074782146","https://openalex.org/W2079208046","https://openalex.org/W2088839547","https://openalex.org/W2118574315","https://openalex.org/W2147123664","https://openalex.org/W2166592825","https://openalex.org/W2568161342","https://openalex.org/W3215022571"],"related_works":["https://openalex.org/W2039755273","https://openalex.org/W2018897037","https://openalex.org/W4385267389","https://openalex.org/W4249261739","https://openalex.org/W2161240002","https://openalex.org/W109999596","https://openalex.org/W2139127187","https://openalex.org/W2022741651","https://openalex.org/W2063355126","https://openalex.org/W2002134787"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}